The observed significant suppression of STAT3 and HIF-1α mRNA levels in F9 cancer cells (absent in fibroblasts) correlates with the anti-cancer effects of exogenous SELENOV and may represent an important aspect of its therapeutic potential. Here, HIF1A is linked to cancer.